Jan 3, 2019   SOURCE: PR NewsWire

Hemostasis Valves Market Worth $175 Million by 2023 - Exclusive Report by MarketsandMarkets(TM)

CHICAGO, January 3, 2019 /PRNewswire/ --

According to the new market research report "Hemostasis Valve Market by Type (Hemostasis Valve Y Connector, Double Y Connector Hemostasis Valve, One Handed), Application (Angioplasty, Angiography), End User (Hospitals), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023", published by MarketsandMarkets(TM), the Hemostasis Valves Market is expected to reach USD 175 million by 2023 from USD 132 million in 2018, at a CAGR of 5.8%.

(Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )

Don't miss out on business opportunities in Hemostasis Valves Market [https://www.marketsandmarkets.com/Market-Reports/hemostasis-valve-market-206116778.html?utm_source=prnewswire&utm_medium=referral&utm_campaign=paidpr ]

The growth in this market is attributed to the increasing number of interventional procedures. Emerging markets will be the key growth hotspots in the Hemostasis Valves Market; a favorable market scenario in these countries will serve to attract a number of players to focus on opportunities there.

The hemostasis valve Y-connectors segment is expected to account for the largest market share in 2018. 

On the basis of type, the Hemostasis Valves Market is segmented into hemostasis valve Y-connectors, double Y-connector hemostasis valves, one-handed hemostasis valves, and other hemostasis valves. In 2018, the hemostasis valve Y-connectors segment is expected to account for the largest share of the Hemostasis Valves Market. The increasing number of interventional procedures worldwide is a key factor driving the growth of this segment.

Browse in-depth TOC on "Hemostasis Valves Market"

65 - Tables    28 - Figures    98 - Pages  

Get Free 10% Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=206116778 [https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=206116778&utm_source=prnewswire&utm_medium=referral&utm_campaign=paidpr ]

Angiography to dominate the Hemostasis Valves Market during the forecast period. 

On the basis of application, the Hemostasis Valves Market is segmented into angiography and angioplasty. The angiography segment is expected to account for the larger market share in 2018. The large share of this segment is attributed to the increasing number of angiography procedures performed worldwide.

North America is estimated to command the largest share of the market in 2018. 

The Hemostasis Valves Market is segmented into four major geographic segments North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America is expected to command the largest share of the global Hemostasis Valves Market, followed by Europe. The large share of the North American market is attributed to increasing number of interventional surgeries and rising geriatric population.

Inquiry Before Buying:  

https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=206116778 [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=206116778&utm_source=prnewswire&utm_medium=referral&utm_campaign=paidpr ]

The major players in the Hemostasis Valves Market are Boston Scientific (US), Abbott (US), Teleflex Incorporated (US), B. Braun Melsungen (Germany), DeRoyal Industries, Inc. (US), Argon Medical (US), Freudenberg Medical (US), and Scitech (Brazil).

Browse Adjacent Markets @ Medical Devices Market [https://www.marketsandmarkets.com/medical-device-market-research-11.html ] Research Reports & Consulting

About MarketsandMarkets(TM)  

MarketsandMarkets(TM) provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets(TM) for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets(TM) are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets(TM) now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets(TM) is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. 

        

        Contact: 
        Mr. Shelly Singh 
        MarketsandMarkets(TM) INC. 
        630 Dundee Road 
        Suite 430 
        Northbrook, IL 60062 
        USA: +1-888-600-6441 
        Email: sales@marketsandmarkets.com

 

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/hemostasis-valve-market.asp

Visit Our Website: https://www.marketsandmarkets.com 


    Photo: 
    https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

SOURCE MarketsandMarkets